Autologous Cell Therapy Market to Reach a Valuation of US $23.7 Billion by the End of 2024
The key players in the global autologous cell therapy market include names such as Phamicell Co. Inc., BioTime Inc., Vericel Corporation, BrainStorm Cell Therapeutics, and Opexa Therapeutics among others. These players in the market are projected to concentrate on strategic business activities such as mergers, takeovers, joint ventures, and partnerships to enter into the local market. In addition to this, with a view to set up subsidiaries and manufacturing plants in the developing economies, the global market for autologous cell...
View full press release